We have been funding expert research since 2016, aiming to ensure that every child and young person has a safe and effective treatment for their cancer, and that they can live long and happy lives post-treatment.
GOTHAM - A phase II trial to assess the activity of Gemtuzumab Ozogamicin Therapy in HAemophagocytic lymphohistiocytosis (HLH)/Macrophage activation syndrome (MAS) or relapsed/refractory cancers
Neurosurgically-applied chemotherapy for childhood brain tumours arising in the posterior fossa using a biodegradable paste
Establishment of an in vitro model of neuroblastoma initiation using pluripotent stem cell differentiation
Clinical and biological factors associated with relapse and length of survival following relapse in UK neuroblastomas
The Little Princess Trust Knowledge Bank of Wilms Tumour
Electrotherapy for childhood brain tumours
Moving Artificial Intelligence of Functional Imaging for children’s tumours into a multi-centre environment through a Clinical Decision Support System
Understanding and therapeutically exploiting clonal evolution in chemo-resistant acute lymphoblastic leukaemia
Targeting gain of function p53 in poor prognosis Wilms' tumour via histone methyltransferase inhibition
